Video – GE Healthcare

Cerianna: Advancing Estrogen Receptor Targeted PET-CT for Breast Cancer Diagnosis and Beyond

estrogen receptor targeted PET CT

Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]

Read More

Latest

GE Healthcare
Cerianna: Advancing Estrogen Receptor Targeted PET-CT for Breast Cancer Diagnosis and Beyond

Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]

Read More
GE Healthcare
Fluorinated Estradiol Imaging with Cerianna PET CT: Enhancing Assessment of Estrogen Receptor Positive Breast Cancer

Dr. Robert Bridwell, MD, Co-Founder, Chief Medical Officer, and Head Clinical Architect at Appian 360 introduced fluorinated estradiol imaging for PET CT technology and discussed its use in breast cancer patients with estrogen receptor-positive tumors. He explained that the technology allows for a more comprehensive assessment of the biology across multiple metastatic lesions, rather […]

Read More
GE Healthcare
DaTscan: Advancing Parkinsonian Syndrome Diagnosis and Safety Precautions

DaTscan is a radiopharmaceutical instrument for assessing adults suspected of Parkinsonian syndrome (PS). Phillip Kuo MD, PhD and Scott Sherman, MD, Phd sheds some light on this tool. DaTscan is proficient in distinguishing essential tremors from those induced by PS, including idiopathic Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). […]

Read More
GE Healthcare
Differentiating Essential Tremor from Parkinsonian Syndromes: The Role of DaTscan

DaTscan injection scan is used for differentiating essential tremor from tremor due to Parkinsonian syndromes. It is contraindicated in patients with known hypersensitivity to the active substance and iodine. Hypersensitivity reactions and thyroid accumulation have been reported following administration of the scan. It is not established as a screening or confirmatory test or for […]

Read More
GE Healthcare
Differentiating Parkinsonian Syndromes: The Role of DaTscan in SPECT Brain Imaging

The article explores the use of DaTscan injection in SPECT brain imaging to distinguish essential tremor from tremor caused by Parkinsonian syndromes. These syndromes include Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. The injection is contraindicated for patients with known hypersensitivity to its components and may lead to thyroid accumulation. Adverse reactions […]

Read More
GE Healthcare
Advancing Breast Cancer Diagnosis and Treatment: The Role of Cerianna And FDG PET Imaging in Personalized Care

Cerianna PET is a diagnostic tool used with FDG PET imaging to detect estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer. It is not useful for imaging other receptors such as HER2 or PR. Tissue biopsy should be used to confirm recurrence of breast cancer and ER status by pathology. Adverse […]

Read More

Latest

AV industry supply chain
Insights on the status of the AV Industry Supply Chain
December 11, 2023

In a time when the AV industry supply chain faces unprecedented challenges, understanding its current status and future trajectory is crucial. In this week’s segment of “Dear Matt,” presented by Vistacom, host Matt Boyer, the Director of Technology at Vistacom, brings his over 30 years of experience in the audiovisual industry to the status […]

Read More
empowering futures
Empowering Futures: How FoodCorps is Revolutionizing Education and Community Well-being through Food
December 11, 2023

Curt Ellis and Rob Harvey, co-CEOs of FoodCorps, are at the forefront of a transformative movement in school food education. They are focused on empowering futures through their innovative approach. Their mission intertwines the essential elements of health, joy, and empowerment, fundamentally recognizing the role of food not only as sustenance but as a […]

Read More
healthcare startups
Healthcare Startups Need More Than Innovation
December 11, 2023

Healthcare startups need more than innovation; they require dynamic leaders willing to take these endeavors beyond the ordinary into uncharted waters to generate unparalleled success and lead the industry forward. In the latest episode of The Healthcare Rethink Podcast, host Brian Urban sits down with multifaceted healthcare leader Jonathan Baktari, MD, CEO of eNational […]

Read More
All Video - GE Healthcare
Cerianna: Advancing Estrogen Receptor Targeted PET-CT for Breast Cancer Diagnosis and Beyond
January 1, 2023

Gary Ulaner , MD, PhD, FACNM discussed targeted estrogen receptor PET CT with Cerianna as a recently FDA-approved technology for identifying patients with recurrent and metastatic breast cancer that can benefit from it. They explained the mechanism of molecular imaging, where a binding agent is linked with a radioactive isotope specific to the target […]

Read More
Fluorinated Estradiol Imaging with Cerianna PET CT: Enhancing Assessment of Estrogen Receptor Positive Breast Cancer
January 1, 2023

Dr. Robert Bridwell, MD, Co-Founder, Chief Medical Officer, and Head Clinical Architect at Appian 360 introduced fluorinated estradiol imaging for PET CT technology and discussed its use in breast cancer patients with estrogen receptor-positive tumors. He explained that the technology allows for a more comprehensive assessment of the biology across multiple metastatic lesions, rather […]

Read More
DaTscan: Advancing Parkinsonian Syndrome Diagnosis and Safety Precautions
January 1, 2023

DaTscan is a radiopharmaceutical instrument for assessing adults suspected of Parkinsonian syndrome (PS). Phillip Kuo MD, PhD and Scott Sherman, MD, Phd sheds some light on this tool. DaTscan is proficient in distinguishing essential tremors from those induced by PS, including idiopathic Parkinson’s disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP). […]

Read More
Differentiating Essential Tremor from Parkinsonian Syndromes: The Role of DaTscan
January 1, 2023

DaTscan injection scan is used for differentiating essential tremor from tremor due to Parkinsonian syndromes. It is contraindicated in patients with known hypersensitivity to the active substance and iodine. Hypersensitivity reactions and thyroid accumulation have been reported following administration of the scan. It is not established as a screening or confirmatory test or for […]

Read More
Differentiating Parkinsonian Syndromes: The Role of DaTscan in SPECT Brain Imaging
January 1, 2023

The article explores the use of DaTscan injection in SPECT brain imaging to distinguish essential tremor from tremor caused by Parkinsonian syndromes. These syndromes include Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy. The injection is contraindicated for patients with known hypersensitivity to its components and may lead to thyroid accumulation. Adverse reactions […]

Read More
Advancing Breast Cancer Diagnosis and Treatment: The Role of Cerianna And FDG PET Imaging in Personalized Care
January 1, 2023

Cerianna PET is a diagnostic tool used with FDG PET imaging to detect estrogen receptor-positive lesions in patients with recurrent or metastatic breast cancer. It is not useful for imaging other receptors such as HER2 or PR. Tissue biopsy should be used to confirm recurrence of breast cancer and ER status by pathology. Adverse […]

Read More
Revolutionizing Breast Cancer Diagnosis: Unveiling the Potential of Cerianna PET Imaging Agent for Estrogen Receptor-Positive Lesions
January 1, 2023

Cerianna is a radiolabeled estrogen imaging agent that can detect estrogen receptor status in metastatic breast cancer. It can show the heterogeneity of estrogen receptor expression in multiple lesions within a patient. It is only useful for patients who are estrogen receptor positive and tissue biopsy should be used to confirm recurrence of breast […]

Read More
Unlocking Estrogen Receptor Status: Cerianna PET Imaging as an Alternative to Biopsy for Challenging Lesions
January 1, 2023

Cerianna is a radioactive diagnostic agent used with PET imaging to detect estrogen receptor positive lesions in patients with recurrent or metastatic breast cancer. It is an adjunct to biopsy and can help avoid the morbidity associated with brain biopsy. However, tissue biopsy should still be used to confirm breast cancer recurrence and […]

Read More
Vscan Air: The Power of a High Performance Handheld Ultrasound System in the Palm of Your Hand
January 1, 2023

Vscan Air is a wireless, portable, handheld ultrasound system that helps you make clinical decisions by quickly ruling in or out a variety of conditions. Gain the power of a high-performance system in a pocket-sized solution. It’s small, lightweight and wireless, providing you with a convenient, durable and flexible ultrasound solution. With Vscan Air, […]

Read More